Ligand validation:4GX1

GLC: alpha-D-glucopyranose

GLC is a Ligand Of Interest in 4GX1 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4GX1_GLC_B_607	27%	27%	0.192	0.838	1.77	1.2	2	-	0	0	100%	1
4GX1_GLC_C_609	14%	28%	0.27	0.818	1.74	1.16	2	1	0	0	100%	1
4GX1_GLC_D_605	10%	29%	0.261	0.761	1.72	1.15	2	2	0	0	100%	1
4GX1_GLC_C_608	8%	28%	0.208	0.685	1.73	1.18	2	1	0	0	100%	1
4GX0_GLC_B_606	36%	27%	0.14	0.831	1.77	1.17	2	1	0	0	100%	1
5O59_GLC_A_608	100%	61%	0.025	0.992	0.81	0.69	-	-	0	0	92%	0.9167
8R4G_GLC_C_1001	100%	39%	0.042	0.991	0.8	1.57	1	3	1	0	100%	1
3W7S_GLC_A_1002	99%	64%	0.046	0.974	0.56	0.83	-	-	0	0	100%	1
5MTT_GLC_A_407	98%	66%	0.053	0.993	0.38	0.92	-	-	0	0	92%	0.5867
8R53_GLC_A_901	98%	61%	0.047	0.969	0.78	0.72	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.